NCT05159453 - Dose Response Study of Transdermal Human Insulin in Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 2, 2025

Primary Completion Date

October 15, 2025

Study Completion Date

December 15, 2025

Conditions

Glucose, High Blood

Interventions

BIOLOGICAL

Human Insulin

International Unit for International Unit exchange of transdermally delivered Human Insulin for injected Human Insulin or combinations of basal and fast-acting insulins.

DEVICE

Finger-actuated, Metered Pump Sprayer

Stock, pharmaceutical grade High Density Polyethylene (HDPE) bottle and HDPE nylon and stainless steel finger-actuated pump sprayer delivering 0.2 mL per pump.

Trial Locations (1)

33410

Langford Research Institute, Palm Beach Gardens

All Listed Sponsors

collaborator

Langford Research Institute, Inc.

INDUSTRY

lead

Transdermal Delivery Solutions Corp

INDUSTRY